Enzymotec Opens New Israel Based Plant

The new state of the art plant includes several production lines, research laboratories and the company's main offices.

20/07/09 Enzymotec has opened its new 200,000 sqft cGMP plant. The president of the state of Israel , Mr. Shimon Peres honored Enzymotec with his presence in the new plant opening ceremony that took place on July 6th at the Sagi 2000 industrial area northern Israel. Approximately 350 guests came from the USA, Canada , Europe and the Far East to attend the event.

"In Israel we are not trying to be champions, we are trying to be pioneers" said Mr. Peres , "even important thing like food can be harmful to the body, however, Enzymotec turns food into a cure" added Mr. Peres.

The new state of the art plant includes several production lines, research laboratories and the company's main offices.

"This plant will enable us to meet the growing global demand of our products and will enable us to extend the line of products we are offering." Says Dr. Ariel Katz Enzymotec CEO.

Enzymotec is a developer and manufacturer of innovative, lipid-based biofunctional solutions for orthomolecular medicine, dietary supplements and advanced infant nutrition. Key products are: SharpPS line of products- phosphatidylserine based ingredients for cognitive improvement, InFat - structured fat for infant formulas, CardiaBeat offering a broad health effect to reduce CVD risks and Krill Oil+.